The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of BL-8040, high-affinity CXCR4 antagonist, on T-cell infiltration, tumor growth, and synergy with immunomodulatory agents.
 
Michal Abraham
Employment - Biokine Therapuetics
 
Inbal Mishalian
No Relationships to Disclose
 
Yaniv Harel
No Relationships to Disclose
 
Shiri Klein
No Relationships to Disclose
 
Yaron Pereg
No Relationships to Disclose
 
Galia Oberkovitz
Employment - BioLineRx
 
Hanna Wald
Employment - Biokine Therapuetics
 
Orly Eizenberg
Employment - Biokine Therapuetics
Stock and Other Ownership Interests - Biokine Therapuetics
 
Baruch Bulvik
No Relationships to Disclose
 
Abi Vainstein Haras
Employment - BioLineRx
 
Arnon Aharon
No Relationships to Disclose
 
Amnon Peled
Employment - Biokine Therapuetics
Stock and Other Ownership Interests - Biokine Therapuetics
Consulting or Advisory Role - BioLineRx